Membrane-Type 1 Matrix Metalloproteinase Stimulates Cell Migration through Epidermal Growth Factor Receptor Transactivation
Proteolysis of extracellular matrix proteins by membrane-type 1 matrix metalloproteinase (MT1-MMP) plays a pivotal role in tumor and endothelial cell migration. In addition to its proteolytic activity, several studies indicate that the proinvasive properties of MT1-MMP also involve its short cytopla...
Gespeichert in:
Veröffentlicht in: | Molecular cancer research 2007-06, Vol.5 (6), p.569-583 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Proteolysis of extracellular matrix proteins by membrane-type 1 matrix metalloproteinase (MT1-MMP) plays a pivotal role in
tumor and endothelial cell migration. In addition to its proteolytic activity, several studies indicate that the proinvasive
properties of MT1-MMP also involve its short cytoplasmic domain, but the specific mechanisms mediating this function have
yet to be fully elucidated. Having previously shown that the serum factor sphingosine 1-phosphate stimulates MT1-MMP promigratory
function through a process that involves its cytoplasmic domain, we now extend these findings to show that this cooperative
interaction is permissive to cellular migration through MT1-MMP–dependent transactivation of the epidermal growth factor receptor
(EGFR). In the presence of sphingosine 1-phosphate, MT1-MMP stimulates EGFR transactivation through a process that is dependent
upon the cytoplasmic domain of the enzyme but not its catalytic activity. The MT1-MMP–induced EGFR transactivation also involves
G i protein signaling and Src activities and leads to enhanced cellular migration through downstream extracellular signal-regulated
kinase activation. The present study, thus, elucidates a novel role of MT1-MMP in signaling events mediating EGFR transactivation
and provides the first evidence of a crucial role of this receptor activity in MT1-MMP promigratory function. Taken together,
our results suggest that the inhibition of EGFR may represent a novel target to inhibit MT1-MMP–dependent processes associated
with tumor cell invasion and angiogenesis. (Mol Cancer Res 2007;5(6):569–83) |
---|---|
ISSN: | 1541-7786 1557-3125 |
DOI: | 10.1158/1541-7786.MCR-06-0267 |